Details for Patent: 8,048,917
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Which drugs does patent 8,048,917 protect, and when does it expire?
Patent 8,048,917 protects HORIZANT and is included in one NDA.
This patent has seventy-one patent family members in twenty countries.
Summary for Patent: 8,048,917
| Title: | Prodrugs of GABA analogs, compositions and uses thereof |
| Abstract: | The present invention provides prodrugs of GABA analogs, pharmaceutical compositions of prodrugs of GABA analogs and methods for making prodrugs of GABA analogs. The present invention also provides methods for using prodrugs of GABA analogs and methods for using pharmaceutical compositions of prodrugs of GABA analogs for treating or preventing common diseases and/or disorders. |
| Inventor(s): | Gallop; Mark A. (Los Altos, CA), Cundy; Kenneth C. (Redwood City, CA), Zhou; Cindy X. (Palo Alto, CA), Yao; Fenmei (Mountain View, CA), Xiang; Jia-Ning (Palo Alto, CA) |
| Assignee: | XenoPort, Inc. (Santa Clara, CA) |
| Application Number: | 11/110,909 |
|
Patent Claim Types: see list of patent claims | Composition; Compound; Dosage form; Use; |
Drugs Protected by US Patent 8,048,917
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Azurity | HORIZANT | gabapentin enacarbil | TABLET, EXTENDED RELEASE;ORAL | 022399-002 | Dec 13, 2011 | RX | Yes | No | See Plans and Pricing | See Plans and Pricing | Y | Y | MANAGEMENT OF POSTHERPETIC NEURALGIA (PHN) IN ADULTS | See Plans and Pricing | ||
| Azurity | HORIZANT | gabapentin enacarbil | TABLET, EXTENDED RELEASE;ORAL | 022399-001 | Apr 6, 2011 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | Y | MANAGEMENT OF POSTHERPETIC NEURALGIA (PHN) IN ADULTS | See Plans and Pricing | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,048,917
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 380029 | See Plans and Pricing | |||
| Austria | 540678 | See Plans and Pricing | |||
| Australia | 2002310409 | See Plans and Pricing | |||
| Australia | 2002345664 | See Plans and Pricing | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
